Skip to Content
Merck
  • Genome-scale CRISPR screening for potential targets of ginsenoside compound K.

Genome-scale CRISPR screening for potential targets of ginsenoside compound K.

Cell death & disease (2020-01-22)
Yuanyuan Yang, Xiaojian Liu, Shuang Li, Yanhao Chen, Yongxu Zhao, Yuda Wei, Yan Qiu, Yan Liu, Zhihua Zhou, Jun Han, Guohao Wu, Qiurong Ding
ABSTRACT

Ginsenosides exhibit a large variety of biological activities in maintaining physical health; however, the molecule underpinnings underlining these biological activities remain to be defined. Here, we took a cellular condition that compound K (CK) induces autophagic cell death in HeLa cells, and setup a high-throughput genetic screening using CRISPR technology. We have identified a number of CK-resistant and CK-sensitive genes, and further validated PMAIP1 as a CK-resistant gene and WASH1 as a CK-sensitive gene. Compound K treatment reduces the expression of WASH1, which further accelerates the autophagic cell death, highlighting WASH1 as an interesting downstream mediator of CK effects. Overall, our study offers an easy-to-adopt platform to study the functional mediators of ginsenosides, and provides a candidate list of genes that are potential targets of CK.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-WASHC1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-γ-Tubulin antibody, Mouse monoclonal, clone GTU-88, ascites fluid
Sigma-Aldrich
3-Methyladenine, autophagy inhibitor
Sigma-Aldrich
Anti-LC3B Antibody, serum, from rabbit